New pill aims to stop deadly filoviruses after exposure
NCT ID NCT06682234
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times
Summary
This study tested whether the drug obeldesivir could safely prevent filovirus disease (like Ebola) in people who were recently exposed. It was designed for high-risk individuals, but the study was withdrawn before enrolling anyone. No results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FILOVIRUS DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.